{"name":"Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.","slug":"exscientia-ai-ltd-a-wholly-owned-subsidiary-of-recursion-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxONU5DSFI4TXdzWmM4NzI2WTh2TjFFVDF5U1hMSWtzbXlTMGVDbl9GV0owTmEzQXpNMUxHLXkwakN5NWpjVjlyWThLaWRQdHZSeVU2WkRxd1g4Q0pTZkFHeEx2V19iV0FzaTBlenRDcGVXY0M4Q0t0ZGtvUEdCSDJLOUp4Wm9YUHRTbzNFcG9CdEVidkk5ajhRTHU2eERRei15UUNTaV92UVU3N0E?oc=5","date":"2026-02-25","type":"pipeline","source":"TradingView","summary":"RECURSION PHARMACEUTICALS, INC. SEC 10-K Report - TradingView","headline":"RECURSION PHARMACEUTICALS, INC. SEC 10-K Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxORkJlX080aUtkNmVKeU5HNzF1VmVod1Q4R004WE1ZUGw3UHo4TDhyaThXMm9UOTVJUkNncHVkRklLMEVldzhqNEFBSFRNQy1CX1RTVGJvZmxRRlRlYTJpVENNdE5CSV9YMUo5LWxXeHlyWVgzc01wdjhPTEhCblVSbk9FQUxlbzZTc0ZuWVZTNXMwZHZTMXdkUW90Tl8xbUlTa1ZfeVlUc040VGc?oc=5","date":"2025-10-20","type":"deal","source":"TechStock²","summary":"Recursion Pharma Stock Soars 16% on AI Buzz and Big Pharma Deals – Can RXRX Keep Climbing? - TechStock²","headline":"Recursion Pharma Stock Soars 16% on AI Buzz and Big Pharma Deals – Can RXRX Keep Climbing? - TechStock²","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE9kcjRkSmZFLXhxcmJRTmZ6c3dncFJNOWZCaE8xM1l6ZHI0RWFGUFRCVlEzTmlabEJQbjkxTExENU9PZGNCdm02SFc2SGVJUjlwN1Qxd1BaSlE3Rzkx?oc=5","date":"2025-07-20","type":"trial","source":"Finimize","summary":"Recursion’s AI Drug Factory Has Big Data, And Bigger Bets - Finimize","headline":"Recursion’s AI Drug Factory Has Big Data, And Bigger Bets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE11RFlnMERhTk5QVW1wZXNQSXRRM2x3UndBaFc3TXdlVXI2WmhkZE9EWnVUODNqcjdEeXl1UFlxN2haM1d4dkYwVUdEQS1LemEySVBTdnpFMGV2NHBPMmFObFVwcWp6RkQ4d296ekVzcjdaZC11?oc=5","date":"2025-03-27","type":"pipeline","source":"Labiotech.eu","summary":"12 AI drug discovery companies you need to watch in 2025 - Labiotech.eu","headline":"12 AI drug discovery companies you need to watch in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNZV90SXRuYUNMWVJCM1ZySm5keDlwRHJzMUUzd0NEc2R0UDc1U1ZwQUZwaW9IVUNRNnY5cjJYcE1aMUJJX2Job3liaGtxX3A0ZzhjX0NaWERjTHRMbVdVZzZjemdxZGYwSWF6TmNYOE4ydVlWUnlLQWRHWG54ZVBDb2lkMC02RzBp?oc=5","date":"2025-02-27","type":"deal","source":"Pharma Voice","summary":"AI deals are surging, and Recursion’s ongoing Exscientia merger points to a new world of integration - Pharma Voice","headline":"AI deals are surging, and Recursion’s ongoing Exscientia merger points to a new world of integration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQY0tmTHFPd2ZFRTFPSkt3TjRVM0ZxYm5jU2o2VTlLSW45OUJfb1E4LWhqZ3hZaVR4TXpkY1JUTHdlWHFtRHdURHhLODNzaGVrTmJOS1YwTUZOU1ZTRnNMdFl1Zi1LV1k1SDBWLS0za19tc3Z5QVYzcWpTZXpYaVNTeTFyY1AzWmgwN21jZlF3M3QyM2NWZ0V5LWtLcG5ITHAzZG5vb1NTd1ZEa3lHb0NWRzlDTEl1cVNxNlFIT1RQWGFlUQ?oc=5","date":"2024-12-12","type":"pipeline","source":"Seeking Alpha","summary":"Recursion: Transforming Drug Discovery With Its AI-Powered Drug Development Platform - Seeking Alpha","headline":"Recursion: Transforming Drug Discovery With Its AI-Powered Drug Development Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQYlRTWGFvZ0NIQVVGdjdsRHRUcW9zenluLWszbXJmZy1NRzZ6eEJRM1FHc004OFZxTGhSUzZNd1J6WEZlOVBRNDkyWERnLTFaQlBqYmJ4REh0WEZNbklNdXpJcVpmNXBvRWcyQ1hkWU9iX3d5a0UtSmtDdVdQNVNoUXRONVbSAYoBQVVfeXFMTnhZVFhEOC1LcTJHdjQ1RzcwMFFJOWpoRmNNaU1DMVk2ZkNNUUx2aUNXeFlMa1hkQjl5WlYycXZ1amlSTmRRQ1hDQmdnRUJtSVZVUXh4VFdIYXBzY1h0bVgzM193Zk5BQUN1UnpsY0VuVVBRRkZQQXpGT0g1dEpuRElJWnNITHpsWTVR?oc=5","date":"2024-11-22","type":"deal","source":"Insider.co.uk","summary":"Exscientia confirms £500 million merger with Recursion - Insider.co.uk","headline":"Exscientia confirms £500 million merger with Recursion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxQcFlpLVpKQkZUWU96M1doR3F2MklvQ2lfWGgxN1pwRHBLRnNpbGJIQ0MzMmNPek5ldUtudHdhbTlrU2xaLUg0MGZsaGx4aTlyczljaWM2bnpiekhOUjN1RHh2QklUVG81RnZQRmVTQXdxRVg1bFhLaTlDVl8ya2dSUlpiVXY5UW9MN19tSVp5RWJ0dHIzUG8yaS1Zb2lWbF8wMXk0WWtIRjRZbG1ZZHpxTU1oR2pYTzRBdnVnSHYxZmY4dWpCeWZTU1pfZFFxUXZGVEw2WUVNZF9vSnVkeGJXZEtfVW9qVFpXOFdyb0lmNF9UX09wVGYtYWdneDE1RFh4enNGaGUybDJSdGlFMHpTclZlbmJLZWJ2RXRLdXlPaGdKdWJ1SzJiR3FKeF9XLTZCZC1sNXBoeU91Sk0?oc=5","date":"2024-11-20","type":"pipeline","source":"GlobeNewswire","summary":"Recursion and Exscientia, two leaders in the AI drug - GlobeNewswire","headline":"Recursion and Exscientia, two leaders in the AI drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNQ0E3ZUxGR0hDVTJ4NDZvcm5LX2VTQkhpaHphbEUyWllIMlp1OEdxRTAwN01BRHVYZzVBRUFDOEpRQjZYSFUweXJ0eHdTbVhwWnBBaFdONnlBX0RZbHp1M2dQY2xmYXVXZWR1RDdFeGhFUEo2VS1YOXdIQU5BQXd0X1RoejJRYUxtbWJ0d2hqNGwyck1PRWc?oc=5","date":"2024-09-30","type":"pipeline","source":"Nanalyze","summary":"Want to Invest in the FUTURE of AI Medicine? Watch This Now - Nanalyze","headline":"Want to Invest in the FUTURE of AI Medicine? Watch This Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQblZUUklITTdSNHR1bms3N254SHN3SmlERW9iTjkwajRVeUNJQm1aSnlQWlltM0k3Yk5hMVhIdF8tZzdfU1dIdnRtbjZFamJGemdRVWh0T3p6X0N6NnlBZ19sOVRHZWhUNkp3ZHBDN3lIVnUwd0lzR2pCci1Ya2Q3VmdFVHNYTThteFBka3gzNEN1dXNRVW5oVkF2R2xreENTYWJjUzctV1FJSGRVX3B5bmYwb2Vma3FabVpnVUNB?oc=5","date":"2024-09-03","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Recursion’s CEO Discusses Pipeline Growth, Approach to AI and ML - Genetic Engineering and Biotechnology News","headline":"Recursion’s CEO Discusses Pipeline Growth, Approach to AI and ML","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPNjJWeGV5WGVpTzdzV2x1YXI1NmZBNmNIeVNuMWFTMEhBMjZjY1pmaVF2LVVlR3dCSjRUbjhEVnRIbWdKLUFCX0lCS1lUX3ZYLXMzeWFZdjBxc0RvWHRxMHlYQWtrNXRXRndSd0pGem14RjFORmZWajdEY3ctZGNqN2R4cm5NZXdzekdyd2VmQkdvbjBBcXhPTm94SEVEWkJ2eTYwaTVWMm9HY2Q4Sm44Mw?oc=5","date":"2024-08-19","type":"pipeline","source":"statnews.com","summary":"AI drug firm Recursion seeks to move from survival to industry domination - statnews.com","headline":"AI drug firm Recursion seeks to move from survival to industry domination","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQd292dXVhak1SMzZzZ3ZSNW14MTRuQk5EN3NTVlBJbWZvU0VOeE80VWhHcjBCRXR1a2szbEdhdUtMSkdOYnktVXBDazlMOTlGZVFZQTYta0RLSVpoWGc5QzVDbVo1MG1JV0FZb05VaEotYzNUQlNSd0JzdEpWWU0tTUxnWTM3WjBocjh0aHN3?oc=5","date":"2021-09-13","type":"pipeline","source":"SEC.gov","summary":"tm2119783-5_f1.htm - SEC.gov","headline":"tm2119783-5_f1.htm","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}